Assessing the neuropsychological profile of stable schizophrenic outpatients

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 8, Issue 4, 1996, Pages 423-428

  Cutler, Neal R ^a,b   Veroff, Amy E ^a   Frackiewicz, Edyta J ^a   Welke, Timothy L ^a   Kurtz, Neil M ^a   Sramek, John J ^a  

^a CALIFORNIA CLINICAL TRIALS   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PRIORITY JOURNAL; RELIABILITY; SCHIZOPHRENIA;

EID: 0029800580     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.8.4.423     Document Type: Article

References (31)

1. Kraepelin E: Dementia Praecox and Paraphrenia. Edinburgh, Scotland, E and S Livingstone, 1919
2. Jaeger J, Douglas E: Neuropsychiatric rehabilitation for persistent mental illness. Psychiatr Q 1992; 63:71-94
3. Delahunty A, Morice R, Frost B: Specific cognitive flexibility rehabilitation in schizophrenia. Psychol Med 1993; 23:221-227
4. Goldberg TE, Weinberger DR: The effects of clozapine on neurocognition: an overview. J Clin Psychiatry 1994; 55(suppl):88-90
5. Lee MA, Thompson PA, Meltzer HY: Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 1994; 55(suppl):82-87
6. Veroff AE, Cutler NR, Sramek JJ, et al: A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test Battery. J Geriatr Psychiatry Neurol 1991; 4:211-217
7. Fleishaker JC, Sisson TA, Sramek JJ, et al: Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test battery. J Clin Pharmacol 1993; 33:463-469
8. Cutler NR, Shrotriya RC, Sramek JJ, et al: The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease. Ann NY Acad Sci 1993; 695:332-336
9. Koda-Kimble MA, Young LY: Applied Therapeutics: The Clinical Use of Drugs. Vancouver, WA, Applied Therapeutics, 1993
10. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
11. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology, revised (DHEW publ no ADM-76-338). Rockville, MD, National Institute of Mental Health, 1976
12. Folstein M, Folstein S, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
13. Simpson G, Angus JSW: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970; 212(suppl):11-19
14. Barnes TR: A rating scale for drug induced akathisia. Br J Pharmacol 1989; 154:672-676
15. Cutler NR, Sramek JJ, Veroff AE: Alzheimer's Disease: Optimizing Drug Development Strategies. Chichester, England, Wiley, 1994
16. Saykin AJ, Gur RC, Gur RE, et al: Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48:618-624
17. Braff DL, Heaton R, Kuck J, et al: The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry 1991; 48:891-698
18. Gruzelier J, Seymour K, Wilson L, et al: Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal function and word fluency in remitting schizophrenia and affective disorders. Arch Gen Psychiatry 1988; 45:623-629
19. Blanchard JJ, Neale JM: The neuropsychological signature of schizophrenia: generalized of differential deficit? Am J Psychiatry 1994; 151:40-48
20. Goldberg TE, Weinberger DR, Berman KF, et al: Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44:1008-1014
21. Sweeney JA, Haas GL, Li S: Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophr Bull 1992; 18:283-293
22. Bilder RM, Lipschutz-Broch L, Reiter G, et al: Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992; 18:437-448
23. Taylor MA, Abrams R: Cognitive impairment in schizophrenia. Am J Psychiatry 1984; 141:196-201
24. Heaton RK: Wisconsin Card Sorting Test, Manual. Odessa, Florida, Psychological Assessment Resources, 1981
25. Benton AL, Hamsher K: Multilingual Aphasia Examination. Iowa City, IA, University of Iowa, 1976
26. Halstead WC: Brain and Intelligence. Chicago, University of Chicago Press, 1947
27. Stroop JR: Studies of interference in serial verbal reaction. J Exp Psychol 1935; 18:643-662
28. Tune LE, Strauss ME, Lew MF, et al: Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry 1982; 139:1460-1462
29. Perlick D, Stastny P, Katz I, et al: Memory deficits and anticholinergic levels in chronic schizophrenia. J Clin Psychol 1986; 143:230-232
30. Fayen M, Goldman MB, Moulthrop MA, et al: Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms. Am J Psychiatry 1988; 145:483-486
31. Chapman LJ, Chapman JP: The measurement of differential deficit. J Psychiatr Res 1978; 14:303-311